Partnerships reshape outcomes. Nicole Richie of Genentech shows how Inclusive Research Site Alliances expand outreach, boost diverse enrollment, and expose design flaws that quietly exclude. Inclusion isn’t a checkbox. It’s a redesign.
👉 shorturl.at/KYmHH
Who gets left out today?

#InclusiveResearch

Want to make medical education more personal, accessible, and trusted? Georgia Spain, AstraZeneca’s Director of Global Oncology Digital Innovation, explores how HCPs engage and what we might be overlooking.

👉Learn more in person this October:
shorturl.at/r7Dmk

#REcustomerEU #MedicalEducation

Launch strategy isn’t just about what you say, it’s how you say it.
Patients need empathy. HCPs need trust. Payers need proof. Advocates need vision.
Learn how to tailor messaging across the board, full rec: bit.ly/3IKdKP2

Which audience do you think gets overlooked?

#MedicalAffairs #PharmaLaunch

“It would be unheard of anywhere else not to listen to customers,” said Nicole Richie, VP & Global Head of Population Science at Genentech.
In pharma, those customers are patients. Trust comes first-especially in rare disease.

➡️Full article:
shorturl.at/meEz1

#PatientCentricity #REclinicalUSA

Clinical trials can miss what matters most. Melody Joy Paine shares a Rett syndrome story that asks: what if lived experience guided how we assess impact? Not everything that counts can be measured.

👉Access the full webinar > shorturl.at/gWBgW

#ClinicalTrials #PatientCentricity

Design for access - not just outcomes.
Simple AI and community-driven evidence can transform pharma, especially for underserved groups.

Page one is where your next launch gets pressure-tested.
👉Read how: shorturl.at/FXxBr

#HealthEquity #PharmaInsights #AIinHealthcare

What does the next-gen clinical trials look like?
Merck, AbbVie, CSL share how AI, real-world data & digital tools are reshaping design, access & patient engagement.

👉 Curious? Full panel info in the agenda:
shorturl.at/7UY0B

#ClinicalTrials #REclinicalUSA

Short, specific, human content wins.
Gen Y HCPs engage 4–5x more with short-form video.
Generic blasts? No longer effective. Gen Y wants relevance, not noise.

Check out all the key takeaways:
👉 shorturl.at/cpUvC

#HCPstrategy #DigitalHealth #GenYInsights #HealthTech

“Who is the payer, how do they decide, and who influences them?” - Yvette Venable on tailoring payer-focused messaging.

👉Watch the full session: bit.ly/3KAc4bk

#MarketAccess #PayerStrategy #Pharma #HealthEconomics #ValueCommunication

Behavioral science is key to changing healthcare decisions, according to Ben Myall. Understand the "six-ton elephant" of emotions and how to drive better outcomes here:
👉 shorturl.at/NocCA

#behaviouralscience #pharmamarketing

AI in pharma is shifting from pilots to practice. Leaders from Teva, Merck, Salesforce, Grifols & Slalom share how agentic AI is driving real impact - from R&D to commercial ops.

➡️Explore the insights:
shorturl.at/OH6aE

What’s the smartest AI move you’ve seen in pharma?

#pharmaAI #AIinPharma

Scaling digital health takes more than tech - it takes trust, collaboration, and shared vision. Pharma leaders are mapping the way forward.
Read the full story (ft. Pfizer, AstraZeneca, Astellas, Boehringer):
shorturl.at/fQLvv
What’s the missing piece in your view?
#DigitalHealth #PharmaPartnerships

Pharma isn’t just adopting AI - it’s rethinking engagement from the ground up.
BMS is showing how modular content, omnichannel fluency & real-world enablement are reshaping HCP experiences.

Catch the panel:
📍Oct 28–29 | Philadelphia
👉 shorturl.at/1Zi5a

#AIinPharma #DigitalHealth

Impact-weighted networks + social listening + machine learning = faster, smarter KOL discovery.
Watch the full webinar for fresh thinking on how data science is reshaping medical influence mapping.
👉 shorturl.at/aKsuv

#PharmaStrategy

From sick care to true health care - leaders from Eli Lilly, PhRMA, Nestle Health Science & MyHealthTeam (a Swoop company), explore how prevention-first strategies are reshaping outcomes.
👉 shorturl.at/bY0pk

#diseaseprevention #healthcare

Generative AI is reshaping how pharma teams work, think, and deliver. Leaders from @novartis.bsky.social , Bayer & Tellius share how agentic workflows are driving real-world impact.
👉 shorturl.at/QWXer
#pharmaAI #agenticAI #medtech #REpharma

Better outcomes start with better engagement. Leaders from BMS, Otsuka & GSK explore how personalization is reshaping pharma’s approach to patient and HCP connection.
➡️ shorturl.at/U1gy0
#pharmaomnichannel #personalizationpharma

We’re seeing AI drive smarter segmentation, better engagement, and measurable ROI.
Which innovation has actually moved the needle for your team?
Curious to hear your take. 👇
#PharmaMarketing #AIinPharma #DigitalEngagement #OmnichannelStrategy #PharmaInnovation #REpharma #REpharmaUSA

💡 Generative AI, including multi-agent systems, could unlock $60–$110 billion in annual value across pharma and medical products, according to McKinsey. That’s up to 4.5% of total industry revenue—clear evidence that innovation delivers measurable impact.
#GenAI #MultiAgentSystems #PharmaTech

Hello Bluesky 👋 Excited to join the conversation! We’re here to share global pharma insights, explore AI in healthcare, and spotlight the changemakers driving life sciences forward. #PharmaInnovation #HealthTech #AIinPharma #LifeSciences
#REpharma